Named as a key player in 33 of our reports, across 33 regions and countries.
Our reports that name Haffkine Bio-Pharmaceutical Corporation Limited as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as Haffkine Bio-Pharmaceutical Corporation Limited (number of shared markets).
Boehringer Ingelheim International GmbH1 shared market
Boston Scientific Corporation1 shared market
CSL Limited1 shared market
Incepta Pharmaceuticals Limited1 shared market
Merck & Co., Inc.1 shared market
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
0 active studies led by Haffkine Bio-Pharmaceutical Corporation Limited, of 1 in all
Source: ClinicalTrials.gov, Studies with Haffkine Bio-Pharmaceutical Corporation Limited (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
The topics of the markets Haffkine Bio-Pharmaceutical Corporation Limited is in.
Stories on the topics Haffkine Bio-Pharmaceutical Corporation Limited works in.
More than half of deaths in low- and middle-income countries come from conditions emergency care could treat…
Read
Road crashes kill about 1.16 million people a year, and more than half of deaths in poorer countries come…
Read
Keeping the airway open is the first step in saving a life. More than half of deaths in low- and…
ReadSearch all reports for Haffkine Bio-Pharmaceutical Corporation Limited All companies